{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02932618",
            "orgStudyIdInfo": {
                "id": "071102"
            },
            "secondaryIdInfos": [
                {
                    "id": "2016-001477-33",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Takeda",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)",
            "officialTitle": "A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-recombinant-von-willebrand-factor-rvwf-with-or-without-advate-in-children-with-severe-von-willebrand-disease-vwd"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-12-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-10-12",
            "studyFirstSubmitQcDate": "2016-10-12",
            "studyFirstPostDateStruct": {
                "date": "2016-10-13",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2023-11-09",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Baxalta now part of Shire",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Takeda Development Center Americas, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main aim of the study is to check effectiveness, side effects, and tolerability of recombinant von Willebrand Factor (rVWF), with or without ADVATE, in the treatment and control of nonsurgical bleeding events in pediatric participants (less than (\\<)18 years of age) with severe hereditary von Willebrand disease (VWD).\n\nThe participants will be treated with rVWF for 12-18 months. Their von Willebrand Disease will be treated by their doctor according to their doctor's usual clinical practice. During the study, participants will be followed up at clinics or over telephone calls."
        },
        "conditionsModule": {
            "conditions": [
                "Von Willebrand Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "On-demand Treatment",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive recombinant von Willebrand factor (rVWF) treatment for non-surgical bleeding episodes over a 12 to 18-month period.",
                    "interventionNames": [
                        "Biological: von Willebrand factor (Recombinant)",
                        "Biological: Antihemophilic Factor (Recombinant)"
                    ]
                },
                {
                    "label": "Elective Surgery",
                    "type": "EXPERIMENTAL",
                    "description": "12-24 hours prior to surgery and within 3 hours of surgery. Minor surgery: infuse every 12-24 hours for at least 48 hours based on post-operative dosing. Oral Surgery: infuse at least once within first 8-12 hours post-surgery based on post-operative dosing. Major Surgery: infuse every 12-24 hours for at least first 96 hours post-surgery based on post-operative dosing.",
                    "interventionNames": [
                        "Biological: von Willebrand factor (Recombinant)",
                        "Biological: Antihemophilic Factor (Recombinant)"
                    ]
                },
                {
                    "label": "Emergency Surgery",
                    "type": "EXPERIMENTAL",
                    "description": "Within 3 hours prior to surgery. Minor surgery: infuse every 12-24 hours for at least 48 hours based on post-operative dosing. Oral Surgery: infuse at least once within first 8-12 hours post-surgery based on post-operative dosing. Major Surgery: infuse every 12-24 hours for at least first 96 hours post-surgery based on post-operative dosing.",
                    "interventionNames": [
                        "Biological: von Willebrand factor (Recombinant)",
                        "Biological: Antihemophilic Factor (Recombinant)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "von Willebrand factor (Recombinant)",
                    "description": "Lyophilized powder and solvent to prepare solution for injection.",
                    "armGroupLabels": [
                        "Elective Surgery",
                        "Emergency Surgery",
                        "On-demand Treatment"
                    ],
                    "otherNames": [
                        "VONVENDI",
                        "rVWF",
                        "BAX111",
                        "BAX 111"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Antihemophilic Factor (Recombinant)",
                    "description": "Packaged in single boxes with 2 glass vials, with one vial containing the lyophilized ADVATE and the second vial containing the diluent.",
                    "armGroupLabels": [
                        "Elective Surgery",
                        "Emergency Surgery",
                        "On-demand Treatment"
                    ],
                    "otherNames": [
                        "ADVATE",
                        "Recombinant Factor VIII",
                        "rFVIII"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Hemostatic Efficacy",
                    "description": "Treatment success for rVWF-treated nonsurgical bleeding episodes (using a 4-point scale: Excellent, Good, Moderate, None).",
                    "timeFrame": "Within 24 hours after the last infusion of study drug following the onset of the bleeding episode (if/when the severity and/or duration of the bleeding requires the infusion of the study drug)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of Treated Nonsurgical Bleeding Episodes With an Efficacy Rating of 'Excellent' or 'Good'",
                    "description": "If/when the severity and/or duration of the bleeding requires the infusion of the study drug.",
                    "timeFrame": "Throughout the study duration of approximately 6.5 years"
                },
                {
                    "measure": "Number of Infusions per Bleeding Episode",
                    "timeFrame": "Throughout the study duration of approximately 6.5 years"
                },
                {
                    "measure": "Number of Recombinant Von Willebrand Factor (rVWF) Units per Bleeding Episode",
                    "timeFrame": "Throughout the study duration of approximately 6.5 years"
                },
                {
                    "measure": "Number of ADVATE Units (if needed) per Bleeding Episode",
                    "timeFrame": "Throughout the study duration of approximately 6.5 years"
                },
                {
                    "measure": "Elective or Emergency Surgery: Assessment of Hemostatic Efficacy - Immediately After Surgery",
                    "description": "Assessed by the operating surgeon, based on a 4-point ordinal scale: Excellent, Good, Moderate, None.",
                    "timeFrame": "Immediately after surgery"
                },
                {
                    "measure": "Elective or Emergency Surgery: Overall Assessment of Hemostatic Efficacy 24 Hours After the Last Perioperative Infusion of rVWF",
                    "description": "Assessed by the Investigator (hematologist) on a 4-point ordinal scale: Excellent, Good, Moderate, None.",
                    "timeFrame": "24 hours after last perioperative rVWF infusion"
                },
                {
                    "measure": "Elective or Emergency surgery: Overall Assessment of Hemostatic Efficacy Day 7 Post-operative",
                    "description": "Assessed by the Investigator (hematologist) on a 4-point ordinal scale: Excellent, Good, Moderate, None.",
                    "timeFrame": "Post-operative Day 7"
                },
                {
                    "measure": "Elective or Emergency surgery: Overall Assessment of Hemostatic Efficacy Day 14 Post-operative",
                    "description": "Assessed by the Investigator (hematologist) on a 4-point ordinal scale: Excellent, Good, Moderate, None.",
                    "timeFrame": "Post-operative Day 14"
                },
                {
                    "measure": "Incidence and Severity of Adverse Events (AEs)",
                    "timeFrame": "Throughout the study period of approximately 6.5 years"
                },
                {
                    "measure": "Incidence of Thrombotic Events",
                    "timeFrame": "Throughout the study period of approximately 6.5 years"
                },
                {
                    "measure": "Incidence of Severe Hypersensitivity Reactions",
                    "timeFrame": "Throughout the study period of approximately 6.5 years"
                },
                {
                    "measure": "Development of Neutralizing Antibodies to von Willebrand Factor (VWF) and Factor VIII (FVIII)",
                    "timeFrame": "Throughout the study period of approximately 6.5 years"
                },
                {
                    "measure": "Development of Total Binding Antibodies to von Willebrand Factor (VWF)",
                    "timeFrame": "Throughout the study period of approximately 6.5 years"
                },
                {
                    "measure": "Development of Antibodies to Chinese Hamster Ovary (CHO) Proteins, Murine Immunoglobulin G (IgG), and rFurin",
                    "timeFrame": "Throughout the study period of approximately 6.5 years"
                },
                {
                    "measure": "Area Under the Plasma Concentration/Time Curve From 0 to 96 Hours Post-Infusion (AUC0-96h) for Von Willebrand factor: ristocetin cofactor (VWF:Rco), von Willebrand factor: antigen (VWF:Ag) and von Willebrand factor: collagen binding capacity (VWF:CB)",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Area Under the Plasma Concentration/Time Curve From Time 0 to Infinity (AUC0-inf) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Mean Residence Time (MRT) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Time to Reach Maximal Plasma Concentration (Tmax) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Maximal Plasma Concentration (Cmax) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Clearance (CL) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Incremental Recovery (IR) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "In-vivo Recovery (IVR) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Elimination Phase Half-life (T1/2) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Volume of Distribution at Steady State (Vss) for VWF:RCo, VWF:Ag and VWF:CB",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                },
                {
                    "measure": "Area Under the Plasma Concentration/Time Curve From 0 to 96 Hours Post-infusion (AUC0-96h) for Factor VIII (FVIII) Activity",
                    "timeFrame": "Within 30 minutes prior to infusion and post infusion at: SEQUENCE 1: 1, 24, 72 hours; SEQUENCE 2: 0.25, 12, and 48 hours; SEQUENCE 3: 6, 30, and 96 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of severe von Willebrand disease (VWD) (defined as von Willebrand factor: ristocetin cofactor \\[VWF:RCo\\] less than \\[\\<\\] 20 percent \\[%\\]):\n\n  * Type 1 (VWF:RCo \\<20 International Units per deciliter \\[IU/dL\\]); or\n  * Type 2A (VWF:RCo \\<20 IU/dL), Type 2B (as diagnosed by genotype), Type 2N (Factor VIII coagulation activity \\[FVIII:C\\] \\<10 % and historically documented genetics), Type 2M; or\n  * Type 3 (VWF:Ag less than or equal to \\[=\\<\\] 3 IU/dL).\n* Age 0 to \\<18 years at the time of Screening.\n* The participant has provided assent (if appropriate) and legally authorized representative(s) has provided informed consent.\n* If female of childbearing potential, participant presents with a negative serum pregnancy test.\n* If applicable, participant agrees to employ adequate birth control measures for the duration of the study.\n* The participant and/or the legally authorized representative are willing and able to comply with the requirements of the protocol, which should also be confirmed based on a pre-screening evaluation held between the Investigator and the Sponsor, to ensure no eminent risk is present that could challenge the participants compliance with the study requirements.\n\nAdditional inclusion criteria for both previously treated participants and participants undergoing surgery are as follows:\n\n* Unable to tolerate or are inadequately responsive to deamino-delta-D-arginine vasopressin (DDAVP).\n* The participant has had a minimum of 1 documented bleed requiring VWF coagulation factor replacement therapy (i.e. treatment with a VWF product) during the previous 12 months prior to enrollment and overall historically 3 or more exposure days (EDs) to VWF replacement therapy.\n\nAdditional inclusion criterion for previously untreated participants are as follows:\n\n- The participant has not received prior VWF coagulation factor replacement therapy.\n\nExclusion Criteria:\n\n* Diagnosis of pseudo-VWD or another hereditary or acquired coagulation disorder (eg, qualitative and quantitative platelet disorders or elevated prothrombin time \\[PT\\]/international normalized ratio \\[INR\\] greater than \\[\\>\\] 1.4).\n* History or presence of a VWF inhibitor at Screening.\n* History or presence of a Factor VIII (FVIII) inhibitor with a titer greater than or equal \\[\\>=\\] 0.4 Bethesda units (BU) (by Nijmegen assay) or \\>=0.6 BU (by Bethesda assay).\n* Documented history of a VWF: RCo half-life \\<6 hours.\n* Known hypersensitivity to any of the components of the study drug, such as mouse or hamster proteins.\n* Medical history of immunological disorders, excluding seasonal allergic rhinitis/conjunctivitis/asthma, food allergies, or animal allergies.\n* Medical history of a thromboembolic event.\n* Human immunodeficiency virus (HIV) positive, with an absolute CD4 count \\<200/ cubic millimeter (mm\\^3).\n* In the judgment of the Investigator, the participant has another clinically significant concomitant disease (e.g. uncontrolled hypertension, cancer) that may pose additional risks for the participant.\n* Diagnosis of significant liver disease, as evidenced by, but not limited to, any of the following: serum alanine aminotransferase (ALT) of 5 times the upper limit of normal; hypoalbuminemia; portal vein hypertension (e.g. presence of otherwise unexplained splenomegaly, history of esophageal varices) or liver cirrhosis classified as Child B or C.\n* Diagnosis of renal disease, with a serum creatinine level \\>=2.5 milligram per deciliter (mg/dL).\n* Immunomodulatory drug treatment other than anti-retroviral chemotherapy (e.g. \u03b1-interferon, or corticosteroid agents at a dose equivalent to hydrocortisone greater than 10 milligram per day \\[mg/day\\] (excluding topical treatment \\[e.g. ointments, nasal sprays\\]), within 30 days prior to signing the informed consent (or assent, if appropriate).\n* If female, participant is pregnant or lactating at the time informed consent (or assent, if appropriate) is obtained.\n* Participant has participated in another clinical study involving an investigational product (IP), other than rVWF with or without ADVATE, or investigational device within 30 days prior to enrollment or is scheduled to participate in another clinical study involving an IP other than rVWF or investigational device during the course of this study.\n* Participant's legal representative is a family member or employee of the Investigator.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Takeda Contact",
                    "role": "CONTACT",
                    "phone": "1-877-825-3327",
                    "email": "medinfoUS@takeda.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Director",
                    "affiliation": "Takeda",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Hemophilia & Thrombosis Center",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "michael.wang@ucdenver.edu"
                        },
                        {
                            "name": "Michael Wang, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Children's National Medical Center",
                    "status": "COMPLETED",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "University of Florida College of Medicine",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32610",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "twynn@peds.ufl.edu"
                        },
                        {
                            "name": "Tung Wynn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "Bleeding and Clotting Disorders Institute",
                    "status": "RECRUITING",
                    "city": "Peoria",
                    "state": "Illinois",
                    "zip": "61615",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "jroberts@ilbcdi.org"
                        },
                        {
                            "name": "Jonathan Roberts, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.69365,
                        "lon": -89.58899
                    }
                },
                {
                    "facility": "Indiana Hemophilia and Thrombosis Center",
                    "status": "COMPLETED",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46260",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "University of Nebraska Medical Center",
                    "status": "COMPLETED",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68198",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "St. Jude Affiliate Clinic at Novant Health",
                    "status": "COMPLETED",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "Comprehensive Cancer Center of Wake Forest Unversity",
                    "status": "COMPLETED",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "eric.mullins@cchmc.org"
                        },
                        {
                            "name": "Eric Mullins, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Rainbow Babies and Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "sanjay.ahuja@uhhospitals.org"
                        },
                        {
                            "name": "Sanjay Ahuja, MD, MSc, MBA",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "Amy.Dunn@nationwidechildrens.org"
                        },
                        {
                            "name": "Amy Dunn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Children's Hospital of Philadelphia",
                    "status": "COMPLETED",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Medical University of South Carolina",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "bergmans@musc.edu"
                        },
                        {
                            "name": "Shayla Bergmann, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "Texas Children's Cancer and Hematology Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "lxvenkat@txch.org"
                        },
                        {
                            "name": "Lakshmi Srivaths, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Texas Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rosa Diaz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Comprehensive Center for Bleeding Disorders",
                    "status": "COMPLETED",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53225",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                },
                {
                    "facility": "Medizinische Universit\u00e4t Innsbruck",
                    "status": "COMPLETED",
                    "city": "Innsbruck",
                    "zip": "6020",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 47.26266,
                        "lon": 11.39454
                    }
                },
                {
                    "facility": "AKH - Medizinische Universit\u00e4t Wien",
                    "status": "RECRUITING",
                    "city": "Vienna",
                    "zip": "1090",
                    "country": "Austria",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "christoph.male@meduniwien.ac.at"
                        },
                        {
                            "name": "Christoph Male, MD, MSc",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.20849,
                        "lon": 16.37208
                    }
                },
                {
                    "facility": "UZ Leuven",
                    "status": "RECRUITING",
                    "city": "Leuven",
                    "zip": "3000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "veerle.labarque@uzleuven.be"
                        },
                        {
                            "name": "Veerle Labarque, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "Fakultni nemocnice Brno",
                    "status": "COMPLETED",
                    "city": "Brno",
                    "zip": "613 00",
                    "country": "Czechia",
                    "geoPoint": {
                        "lat": 49.19522,
                        "lon": 16.60796
                    }
                },
                {
                    "facility": "H\u00f4pital Morvan",
                    "status": "COMPLETED",
                    "city": "Brest",
                    "state": "Finistere",
                    "zip": "29609",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.3903,
                        "lon": -4.48628
                    }
                },
                {
                    "facility": "Groupe Hospitalier Pellegrin - H\u00f4pital Pellegrin",
                    "status": "RECRUITING",
                    "city": "Bordeaux Cedex",
                    "zip": "33000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "yoann.huguenin@chu-bordeaux.fr"
                        },
                        {
                            "name": "Yoann Huguenin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "Groupement Hospitalier Est- H\u00f4pital Louis Pradel",
                    "status": "RECRUITING",
                    "city": "Bron cedex",
                    "zip": "69677",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "lucia.rugeri@chu-lyon.fr"
                        },
                        {
                            "name": "Lucia Rugeri, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.73333,
                        "lon": 4.91667
                    }
                },
                {
                    "facility": "CHU CAEN - H\u00f4pital de la C\u00f4te de Nacre",
                    "status": "RECRUITING",
                    "city": "Caen cedex 9",
                    "zip": "14033",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "borelderlon-a@chu-caen.fr"
                        },
                        {
                            "name": "Annie Borel-Derlon, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.18585,
                        "lon": -0.35912
                    }
                },
                {
                    "facility": "Groupement Hospitalier Sud - H\u00f4pital Bic\u00eatre",
                    "status": "RECRUITING",
                    "city": "Le Kremlin-Bic\u00eatre",
                    "zip": "94270",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "roseline.doiron@aphp.fr"
                        },
                        {
                            "name": "Roseline D oiron, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.81471,
                        "lon": 2.36073
                    }
                },
                {
                    "facility": "Hopital Cardiologique - CHU Lille",
                    "status": "RECRUITING",
                    "city": "Lille Cedex",
                    "zip": "59037",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "sophie.susen@chru-lille.fr"
                        },
                        {
                            "name": "Sophie Susen, MD, MSc, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "CHU de Nantes Site Hotel Dieu",
                    "status": "COMPLETED",
                    "city": "Nantes Cedex 1",
                    "zip": "44093",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "H\u00f4pital Necker - Enfants Malades",
                    "status": "RECRUITING",
                    "city": "Paris cedex 15",
                    "zip": "75743",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "annie.harroche@aphp.fr"
                        },
                        {
                            "name": "Annie Harroche-Angel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Universitaetsklinikum Hamburg-Eppendorf",
                    "status": "COMPLETED",
                    "city": "Hamburg",
                    "zip": "20246",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 53.57532,
                        "lon": 10.01534
                    }
                },
                {
                    "facility": "Werlhof-Institut GmbH",
                    "status": "COMPLETED",
                    "city": "Hannover",
                    "zip": "30159",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.37052,
                        "lon": 9.73322
                    }
                },
                {
                    "facility": "Medizinische Hochschule Hannover",
                    "status": "COMPLETED",
                    "city": "Hannover",
                    "zip": "30625",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.37052,
                        "lon": 9.73322
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Universitaria Careggi",
                    "status": "RECRUITING",
                    "city": "Firenze",
                    "zip": "50134",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "castaman@aou-careggi.toscana.it"
                        },
                        {
                            "name": "Giancarlo Castaman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.77925,
                        "lon": 11.24626
                    }
                },
                {
                    "facility": "Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20122",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "flora.peyvandi@unimi.it"
                        },
                        {
                            "name": "Flora Peyvandi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Pediatrica Santobono Pausillipon",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80122",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "mischiavulli@gmail.com"
                        },
                        {
                            "name": "Michele Schiavulli, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Ospedale Pediatrico Bambino Ges\u00f9",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00165",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "matteo.luciani@opbg.net"
                        },
                        {
                            "name": "Matteo Luciani, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Erasmus Medisch Centrum",
                    "status": "COMPLETED",
                    "city": "Rotterdam",
                    "zip": "3015 CN",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "SBEI HPE Altai State Medical University of MoH and SD",
                    "status": "COMPLETED",
                    "city": "Barnaul",
                    "zip": "656038",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 53.36056,
                        "lon": 83.76361
                    }
                },
                {
                    "facility": "SAIH \"Kemerovo Regional Clinical Hospital\"",
                    "status": "COMPLETED",
                    "city": "Kemerovo",
                    "zip": "650066",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.33333,
                        "lon": 86.08333
                    }
                },
                {
                    "facility": "FSBI of Science \"Kirov Scientific and Research Institute of Hematology and Blood Transfusion of FMBA",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Kirov",
                    "zip": "610027",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 58.59665,
                        "lon": 49.66007
                    }
                },
                {
                    "facility": "Hospital General Universitario de Alicante",
                    "status": "RECRUITING",
                    "city": "Alicante",
                    "zip": "03010",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "marco_pas@gva.es"
                        },
                        {
                            "name": "Pascual Marco Vera, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.34517,
                        "lon": -0.48149
                    }
                },
                {
                    "facility": "Hospital Universitari i Politecnic La Fe",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46026",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "cid_ana@gva.es"
                        },
                        {
                            "name": "Ana Rosa Cid Haro, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Istanbul University Cerrahpasa Medical Faculty",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34098",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "bulent.zulfikar@istanbulmedicare.com"
                        },
                        {
                            "name": "Osman Bulent Zulfikar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Ege University Medical Faculty",
                    "status": "RECRUITING",
                    "city": "Izmir",
                    "zip": "35100",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "KAAN.KAVAKLI@EGE.EDU.TR"
                        },
                        {
                            "name": "Ramazan Kavakli",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.41273,
                        "lon": 27.13838
                    }
                },
                {
                    "facility": "Ondokuz Mayis Univ. Med. Fac.",
                    "status": "RECRUITING",
                    "city": "Samsun",
                    "zip": "55139",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Site Contact",
                            "role": "CONTACT",
                            "email": "calbayrak@omu.edu.tr"
                        },
                        {
                            "name": "Canan Albayrak, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.27976,
                        "lon": 36.3361
                    }
                },
                {
                    "facility": "SI Institute of Blood Pathology and Transfusion Medicine of NAMSU",
                    "status": "COMPLETED",
                    "city": "Lviv",
                    "zip": "79044",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 49.83826,
                        "lon": 24.02324
                    }
                },
                {
                    "facility": "Royal Manchester Children's Hospital",
                    "status": "COMPLETED",
                    "city": "Manchester",
                    "state": "Greater Manchester",
                    "zip": "M13 9WL",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "To obtain more information on the study, click here/on this link",
                    "url": "https://clinicaltrials.takeda.com/study-detail/5f6b5fc34db2bf003ab45926"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Takeda provides access to the de-identified individual participant data (IPD) for eligible studies to aid qualified researchers in addressing legitimate scientific objectives (Takeda's data sharing commitment is available on https://clinicaltrials.takeda.com/takedas-commitment?commitment=5). These IPDs will be provided in a secure research environment following approval of a data sharing request, and under the terms of a data sharing agreement.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR"
            ],
            "accessCriteria": "IPD from eligible studies will be shared with qualified researchers according to the criteria and process described on https://vivli.org/ourmember/takeda/. For approved requests, the researchers will be provided access to anonymized data (to respect patient privacy in line with applicable laws and regulations) and with information necessary to address the research objectives under the terms of a data sharing agreement.",
            "url": "https://vivli.org/ourmember/takeda/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014842",
                    "term": "Von Willebrand Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000025861",
                    "term": "Blood Coagulation Disorders, Inherited"
                },
                {
                    "id": "D000001778",
                    "term": "Blood Coagulation Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000020147",
                    "term": "Coagulation Protein Disorders"
                },
                {
                    "id": "D000001791",
                    "term": "Blood Platelet Disorders"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7796",
                    "name": "Emergencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "relevance": "LOW"
                },
                {
                    "id": "M17585",
                    "name": "Von Willebrand Diseases",
                    "asFound": "Von Willebrand Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M23095",
                    "name": "Blood Coagulation Disorders, Inherited",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21982",
                    "name": "Coagulation Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5072",
                    "name": "Blood Platelet Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005169",
                    "term": "Factor VIII"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003029",
                    "term": "Coagulants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M8312",
                    "name": "Factor VIII",
                    "asFound": "Behcet's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6259",
                    "name": "Coagulants",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                }
            ]
        }
    },
    "hasResults": false
}